Otsuka Corporation (TYO:4768)
Japan · Delayed Price · Currency is JPY 3,223.00
-15.00 (-0.46%)
Jan 23, 2026, 3:30 PM JST
Otsuka Employees
Otsuka had 9,680 employees as of December 31, 2024. The number of employees increased by 472 or 5.13% compared to the previous year.
Employees
9,680
Change
472
Growth
5.13%
Revenue / Employee
133.38M JPY
Profits / Employee
6.55M JPY
Market Cap
1.22T
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 9,680 | 472 | 5.13% |
| Dec 31, 2022 | 9,208 | 37 | 0.40% |
| Dec 31, 2021 | 9,171 | 52 | 0.57% |
| Dec 31, 2020 | 9,119 | 387 | 4.43% |
| Dec 31, 2018 | 8,732 | 74 | 0.85% |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Kaga Electronics | 8,560 |
| Daiwabo Holdings | 2,928 |
| Mimaki Engineering | 2,114 |
| Innotech | 1,560 |
| DAIKO XTECH | 1,323 |
| Marubun | 1,179 |
| Sun-Wa Technos | 1,085 |
| Senshu Electric | 825 |
Otsuka News
- 9 days ago - LARGE CAP INTERNATIONAL PORTFOLIO Buys Shares of Otsuka Corp (4768) - GuruFocus
- 5 weeks ago - 4D Molecular Therapeutics: Jury Still Out On CF Gene Therapy After Dense Data Drop - Seeking Alpha
- 5 weeks ago - Otsuka Initiates Global Phase 3 Trial Of Repinatrabit For Phenylketonuria - Nasdaq
- 2 months ago - FDA Approves Otsuka's (OTSKF) Voyxact for IgAN Treatment - GuruFocus
- 2 months ago - Otsuka gains FDA approval for sibeprenlimab for proteinuria reduction - Seeking Alpha
- 2 months ago - FDA Grants Accelerated Approval For Otsuka's VOYXACT In IgAN - Nasdaq
- 3 months ago - Otsuka 9-month Profit Rises; Revenue Up 5.1% - Nasdaq
- 6 months ago - Otsuka’s PTSD therapy draws efficacy concerns at FDA ahead of AdCom meeting - Seeking Alpha